First flows the preliminary result of clinical trial of vaccine reveals it is safe and reliable

First flows the preliminary result of clinical trial of vaccine reveals it is safe and reliable
First flows the preliminary result of clinical trial of vaccine reveals it is safe and reliable
Reporter abundant and sincere news from Beijing on July 28 paid close attention to by Ministry of Public Health, national Bureau of Drugs Supervision in Liu, accused of centre's organizing by China's disease, disease in Beijing accuses of centre's bearing, the department of Beijing revitalizes the clinical experiment work of first type H1N1 influenza vaccine that biologicals Co., Ltd. produce and makes good progress, all experimenters have already finished the first stitch inoculating and observation of security of 3 days, the preliminary result reveals vaccine is safe and reliable. This clinical trial begins from 6 o'clock on July 22 early morning, inoculate to the first stitch that finishes 1614 experimenters in batches on July 25, 101 seniors classes among them, 706 adult's groups, 404 juniors classes, 403 children's groups. At present, all experimenters have already finished the security observations of 3 days after inoculating, has not had serious bad reaction / incident report.


|